“…For instance, while oxidation reactions, which are important for synthesizing alcohols, ketones, aldehydes and acids, are widely used in industry for the production of simple commodity chemicals, they are comparatively rarely applied in pharmaceutical syntheses, because conventional catalysts are poorly selective towards complex molecules and require harsh operating conditions. [1][2][3][4][5] Consequently, biocatalytic oxidations, which are far more selective and require significantly milder operating conditions (room temperature and pressure, as well as neutral pH), are becoming increasingly attractive for industrial implementation. [6][7][8] However, since the pharmaceutical industry and its regulators are shifting in favor of continuous end-to-end manufacturing, to improve the agility and flexibility with which drugs can be supplied [9][10][11][12][13] , biocatalysis must also follow suit.…”